Tzuri Lifschytz

This study compares the acute pharmacology and long-term neuroplastic effects of DMT and 5-MeO-DMT in mice, showing distinct behavioral and molecular outcomes.

This study shows that MDMA combined with exposure therapy rapidly reduces PTSD-like behaviors in a mouse model, supporting its potential for more efficient PTSD treatment.

This study combines psilocybin with NMDAR modulators to enhance therapeutic effects and reduce adverse effects in mice, showing improved neuroplasticity and reduced hallucinogenic and antipsychotic-like behaviors.

This study examines anxiety-like behaviors and synaptic plasticity in juvenile SAPAP3-KO mice before OCD-like grooming emerges, finding no psilocybin treatment effect and age-dependent synaptic changes.

This study shows that a single dose of psilocybin or psychedelic mushroom extract reduces excessive self-grooming in SAPAP3 KO mice, with effects lasting up to 7 weeks.

This study investigates the role of 5-HT2A, 5-HT2C, 5-HT1A, and TAAR1 receptors in modulating head twitch response induced by 5-HTP and psilocybin in mice, showing their potential therapeutic relevance.

This study evaluates the effects of phycocyanin-rich Spirulina extract on mouse behavior, finding significant increases in activity but no antidepressant, anti-anxiety, or cognitive benefits.